The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
TLSI
Executives are unusually accumulating this biotech stock while analysts see triple-digit upside!
TriSalus Life Sciences, Inc, a company developing technology for treating cancerous tumors, is seeing significant purchases by executives after a mixed quarterly report.
Other Stories
Super unusual activity in a small and dangerous company!
PremiumInsidersTENX8h ago2 min read
5 investment firms cut targets, and the executive bought anyway. Since then: 92.6% increase
PremiumInsidersNIQ9h ago2 min read
Unusual insider buying alert
PremiumInsidersINBX10h ago2 min read